Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M402044200 on June 18, 2004

J. Biol. Chem., Vol. 279, Issue 34, 35384-35391, August 20, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/34/35384    most recent
M402044200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suntharalingam, M.
Right arrow Articles by Wente, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suntharalingam, M.
Right arrow Articles by Wente, S. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nuclear Export of the Yeast mRNA-binding Protein Nab2 Is Linked to a Direct Interaction with Gfd1 and to Gle1 Function*

Mythili Suntharalingam{ddagger}, Abel R. Alcázar-Román, and Susan R. Wente§

From the Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232

Received for publication, February 24, 2004 , and in revised form, June 10, 2004.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nuclear export of mRNA is mediated by interactions between soluble factors and nuclear pore complex (NPC) proteins. In Saccharomyces cerevisiae, Nab2 is an essential RNA-binding protein that shuttles between the nucleus and cytoplasm. The mechanism for trafficking of Nab2-bound mRNA through the NPC has not been defined. Gle1 is also required for mRNA export, and Gle1 interactions with NPC proteins, the RNA helicase Dbp5, and Gfd1 have been reported. Here we report that Nab2, Gfd1, and Gle1 associate in a complex. By using immobilized recombinant Gfd1, Nab2 was isolated from total yeast lysate. A similar biochemical assay with immobilized recombinant Nab2 resulted in coisolation of Gfd1 and Gle1. A Nab2-Gfd1 complex was also identified by coimmunoprecipitation from yeast lysates. In vitro binding assays with recombinant proteins revealed a direct association between Nab2 and Gfd1, and two-hybrid assays delineated Gfd1 binding to the N-terminal Nab2 domain. This N-terminal Nab2 domain is distinct from its RNA binding domains suggesting Nab2 could bind Gfd1 and RNA simultaneously. As Nab2 export was blocked in a gle1 mutant at the restrictive temperature, we propose a model wherein Gfd1 serves as a bridging factor between Gle1 and Nab2-bound mRNA during export.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Trafficking of molecules between the nucleus and cytoplasm proceeds through portals known as nuclear pore complexes (NPCs).1 NPCs are embedded in a pore formed by the fusion of the inner and outer membranes of the nuclear envelope. Yeast and vertebrate NPCs are highly conserved in architecture with a characteristic nuclear basket, 8-fold central spoke-ring structure that forms an aqueous channel, and cytoplasmic filaments (1). Proteomic analysis has revealed that NPCs are composed of ~30 distinct nucleoporins (Nups) (2, 3). Although diffusion accounts for the movement of small molecules, such as ions and metabolites, a facilitated, energy-dependent process mediates the rapid transport of larger molecules, such as proteins and mRNA (4). Transport rates for macromolecules are estimated at ~520–1000 molecules/s/NPC (5, 6).

Protein import and export pathways are mediated by karyopherins (Kaps), a family of shuttling transport factors (7). Kaps bind their cargo by recognition of a nuclear localization sequence for import or a nuclear export sequence for export (8). Key steps in movement through the NPC include initial docking of the Kap-cargo complex, translocation through the aqueous channel, and release of the cargo (9). These are presumably dictated by direct interactions between Kaps and Nups (10, 11). The directionality of transport is regulated by the small GTPase Ran (10, 12). High nuclear RanGTP levels are maintained by the compartmentalization of the guanine nucleotide exchange factor to the nucleus and the GTPase-activating protein to the cytoplasm. Thus, during import, high RanGTP levels facilitate release of cargo from the Kap in the nucleus. In contrast, during export, cargo binding to the Kap is enhanced in the nucleus, and release is triggered by RanGTP hydrolysis in the cytoplasm.

Remarkable progress has also been made in the past decade toward identifying factors that play a role in mRNA export. Current models for mRNA export predict the existence of multiple steps at both the nuclear and cytoplasmic faces of the NPC. Recent studies also suggest that packaging the mRNA for export could start as early as transcription (reviewed in Refs. 4 and 13). During transcription and pre-mRNA processing, the RNA is bound by heterogeneous nuclear ribonucleoproteins (hnRNPs). Some hnRNPs contain nuclear retention signals and are removed from the mRNA prior to export, whereas others shuttle between the nucleus and cytoplasm (14).

In the budding yeast Saccharomyces cerevisiae, Nab2, Hrp1, and Npl3 are shuttling hnRNPs (1517). Nab2 is imported into the nucleus by an interaction with Kap104 (18, 19). Within the nucleus, Nab2 has roles linked to the Thp1 transcription complex, the regulation of pre-mRNA polyadenylation and mRNA processing, and mRNA export (2023). The Nab2 export mechanism is dependent on the ubiquitin ligase Tom1 and the arginine methyltransferase Hmt1 (24, 25). However, it is unclear how ubiquitination and methylation affect the pathway. A recent report (26) shows that one export step involves Nab2 binding to Mlp1 on the nuclear face of the NPC. Movement through the NPC may require further interactions with Nups or NPC-associated factors. Because mRNA is tightly linked to hnRNPs, delineating the molecular pathways for mRNA export will require an understanding of the interplay between these mRNA-binding proteins and export factors.

Many studies have focused on dissecting the role of budding yeast Mex67 (Tap/NXF1 in vertebrates) in mRNA export pathway. Mex67 forms a heterodimer with another export factor, Mtr2, binds the hnRNP-like factor Yra1, and interacts with FG (phenylalanine, glycine) repeats in several Nups (2729). Functional associations have also been established between Mex67 and the TREX complex through Yra1 and the splicing factor Sub2 (3032). Mex67, Yra1, and Sub2 have all been further linked to the SAGA histone acetylase complex (22). Thus, Mex67 is a key player in connecting transcription and mRNA export. Other non-hnRNP factors with roles in mRNA export are Dbp5, Gle1, and Gle2/Rae1 (3338). Dbp5 is a DEAD box RNA helicase that localizes to the cytoplasmic face of the NPC through an interaction with Nup159 (39, 40). The unwindase activity could provide directionality and represent a terminal step in mRNA export. Recent work (41) has demonstrated that Dbp5 also has a role in transcription. Gle2 is required for efficient mRNA export in yeast and has a docking site on Nup116 (37, 42, 43). The role of Gle2/Rae1 in vertebrate cells is not clear because mouse embryo fibroblasts and blastocytes from knock out mice exhibit cell cycle defects but not mRNA export defects (44). However, a complex of Gle2/Rae1, Nup98, and Mex67/Tap/NXF1 has been detected in vitro (45).

Our objective has been to provide insight into Gle1-mediated mRNA export. In budding yeast, Gle1 localizes to NPCs at steady state, and gle1 mutants rapidly accumulate poly(A)+ RNA in the nucleus (36). GLE1 was initially identified in budding yeast by a synthetic lethal screen with a nup100{Delta} mutant (36) and as a multicopy suppressor of a nup159/rat7 mutant (46). Genetic and physical interactions have also been shown between Gle1 and Nup42/Rip1 (36, 47, 48). Besides the interactions with Nups, Gle1 also binds Dbp5 and a novel factor Gfd1 (40, 48). GFD1 is a multicopy suppressor of gle1-8 and dbp5-2 mutants (40, 48). Gfd1 localizes to the cytoplasm and nuclear rim and interacts with Gle1, Dbp5, and Nup42 by two-hybrid analysis (40, 48). Precisely how Gfd1 plays a role in Gle1-mediated mRNA export has not been defined. Finally, the nucleocytoplasmic shuttling of the human (h) homolog hGle1 is required for mRNA export (49), but it is unknown whether Gle1 shuttles in S. cerevisiae.

Even though evidence exists for Gle1 having a role in mRNA export in S. cerevisiae and vertebrate cells, its connection to the cargo mRNA has not been delineated. To understand the Gle1-mRNA export pathway, we have focused here on the roles of Nab2 and Gfd1. Our studies demonstrate that Nab2 and Gfd1 associate in a complex both in vivo and in vitro. We find that the N-terminal domain of Nab2 interacts with Gfd1. Most interestingly, recent work (23) has shown that the N-terminal domain of Nab2 is required for poly(A)+ RNA export, and we observed a Nab2 export block in gle1-4 mutant cells. Overall, our results support a model wherein the recruitment of Gle1 to a Nab2 complex represents a step in the mRNA export pathway.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Yeast Strains and Plasmids—All yeast strains used in this study are listed in Table I. The sequence encoding the green fluorescent protein (GFP) was fused in-frame before the stop codon for the chromosomal GFD1 by using the gene integration method by Baudin et al. (50). PCR products were generated with oligonucleotides and a template containing sequences encoding GFP and the Schizosaccharomyces pombe HIS5 (pGFP-HIS5; kindly provided by J. Aitchison). The resulting DNA fragment was transformed into SWY518 by using the lithium acetate method, and colonies were selected on media lacking histidine. Correct integration was confirmed by immunoblotting with affinity-purified rabbit polyclonal anti-GFP antibodies (kindly provided by M. Linder). The resulting strain was back-crossed twice, and the GFP-tagged progeny was used in this study. The plasmids used in this study are listed in Table II and were maintained in either BL21 (Nab2-GST (18), pSW1279, and pSW1296) and/or DH5{alpha} (all others). Expression vector references are as follows: pGAD-C1 and pGBD-C1 (51); pGEX-5X (Amersham Biosciences); and pMAL-cR1 (New England Biolabs).


View this table:
[in this window]
[in a new window]
 
TABLE I
Yeast strains used in this study

 


View this table:
[in this window]
[in a new window]
 
TABLE II
Plasmids used in this study

 
Yeast Two-hybrid Analysis—Gal4AD-Gfd1 and Gal4BD-Nab2 constructs were cotransformed into the two-hybrid reporter strain PJ69-4A. Transformants were selected on SC medium lacking leucine and tryptophan and assayed for interaction by growth on SC medium lacking leucine, tryptophan, histidine, and adenine. Growth was scored at 30 °C. All plasmids were tested for specificity and the ability to self-activate using Gal4AD-Snf4 and Gal4BD-Snf1.

Affinity Chromatography—This assay was performed as described previously (52). For the yeast extracts, wild type (SWY518) or Gle1-TAP-tagged (62) cells were lysed in 20 mM Hepes, pH 6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 250 mM sorbitol, 0.1 mg/ml phenylmethylsulfonyl fluoride (PMSF), 1 µg/ml pepstatin, 2 µg/ml aprotinin, and 2 µg/ml leupeptin by passing through a French press. Following centrifugation at 30,000 x g for 30 min at 4 °C, the supernatant was filtered through a 0.45-µm filter and desalted in a Sephadex G-25 fine column. The lysate was supplemented with 0.1% Tween 20, 2 mM DTT, and complete protease inhibitor mixture (Roche Applied Science). For recombinant protein, Escherichia coli cells with pGEX-5X (GST), pSW1296 (GST-Gfd1), or Nab2-pGEX2TK (Nab2-GST) were grown at 37 °C in 1 liter of 2x YT medium containing 100 µg/ml carbenicillin and 2% glucose to an A600 of 1. Protein expression was induced with 0.3 mM isopropyl-1-thio-{beta}-D-galactopyranoside for 3 h at 37 °C. Cells were resuspended in 30 ml of ice-cold 50 mM Tris, pH 8.0, 100 mM NaCl, and 2 mM EDTA containing PMSF and complete protease inhibitor mixture (Roche Applied Science) and lysed in a French press. Following centrifugation at 30,000 x g for 15 min at 4 °C, the supernatant was supplemented with 0.1% Tween 20. Aliquots of yeast and E. coli lysates were frozen in liquid nitrogen and stored at –70 °C.

For the binding assay, E. coli extracts were incubated with glutathione-Sepharose beads (Amersham Biosciences) for 20 min at 4 °C. The beads were washed three times in binding buffer (20 mM Hepes, pH 6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, 0.1% Tween 20), two times with binding buffer containing 0.1 mM ATP, and two times with binding buffer containing 1 M NaCl. The beads were incubated with 1 ml of yeast lysate or binding buffer alone for2hat4 °C and then washed six times with binding buffer. Bound proteins were eluted with 100 µlof1 M NaCl followed by boiling in SDS sample buffer or eluted directly by boiling in SDS sample buffer. Proteins eluted with 1 M NaCl were precipitated with trichloroacetic acid/sodium deoxycholate. Blots were probed with monoclonal anti-Nab2 antibodies (kindly provided by J. Aitchison) diluted 1:4000, rabbit polyclonal anti-Gle1 antibodies diluted 1:200, or rabbit anti-Gfd1 peptide antibodies diluted 1:200 (overnight, 4 °C). Bound proteins were detected using peroxidase-labeled anti-mouse IgG or anti-rabbit IgG (1h, 23 °C) and developed by enhanced chemiluminescence (Amersham Biosciences) for anti-Nab2 and anti-Gfd1 or SuperSignal West Femto chemiluminescence (Pierce) for anti-Gle1.

Antibodies—MBP-Gle1 was expressed and purified as described previously (37). The antigen was sent to Cocalico Biologicals for production of rabbit antiserum WU851. Antiserum to Gle1 was purified by affinity chromatography over a GST-Gle1 Affi-Gel 10 column (Bio-Rad) as described previously (37). Anti-Gfd1 peptide antibodies (Gfd1D/1) were generated by Bethyl Laboratories. Bethyl Laboratories synthesized the peptides Gfd1D9R25 (CDAPDEEPIKKQKPSHKR) and Gfd1K85K101 (CKISPVSESLAINPFSQK) for production of rabbit antiserum and purified the antiserum against the Gfd1D9R25 peptide.

Immunoprecipitation—Cultures of SWY518 (Gfd1) and SWY2535 (Gfd1-GFP) were grown to an A600 of ~0.5 in rich medium (YPD; 1% yeast extract, 2% peptone, 2% glucose). Whole cell lysates were prepared by glass bead lysis in 20 mM Tris, pH 6.5, 150 mM NaCl, 5 mM MgCl2, 2% Triton X-100 supplemented with complete protease inhibitor mixture and 1 mM PMSF. Immunoprecipitations were conducted as described previously (53). Briefly, 2 µl of anti-GFP antibody was mixed with 200 µl of cell extract and 50 µl of protein A-Sepharose beads for 1.5hat4 °C. The beads were washed six times with 50 mM Tris, pH 6.5, 150 mM NaCl, 0.05% Tween 20 before elution. Blots were probed with anti-Nab2 monoclonal antibodies at a 1:3000 dilution (overnight, 4 °C) and peroxidase-labeled anti-mouse IgG (1 h, 23 °C). The blots were developed by enhanced chemiluminescence.

Purification of Protein and Soluble Binding Assay—E. coli strains containing pGEX-5X (GST) or pSW1296 (GST-Gfd1) were grown in 1 liter of LB media containing 100 µg/ml carbenicillin and 2% glucose at 37 °C. When the A600 was ~1, cultures were induced for 3 h with 0.3 mM isopropyl-1-thio-{beta}-D-galactopyranoside, and cell pellets were frozen at –70 °C. Thawed pellets were resuspended in ice-cold lysis buffer (20 mM sodium phosphate, pH 7.3, 150 mM NaCl, 10 mM EDTA, 0.1 mM DTT) supplemented with complete protease inhibitor mixture and 0.1 mM PMSF and lysed in a French press. The suspension was centrifuged at 9000 x g for 30 min, and Triton X-100 was added to a final concentration of 1%. The supernatant was diluted in lysis buffer containing 1% Triton X-100 and incubated with glutathione-Sepharose resin for 2 h at 4 °C. After washing the resin with 10 ml of lysis buffer containing 1% Triton X-100 and 25 ml of lysis buffer, the beads were packed into a column. The column was washed with lysis buffer until the A280 of the flow-through was ~0. The protein was eluted in 50 mM Tris, pH 9.0, 10 mM glutathione.

MBP and MBP-Nab2 were purified as described above with the following modifications. The lysis buffer was 10 mM sodium phosphate, pH 7.2, 30 mM NaCl, 0.25% Tween 20, 10 mM EDTA, 10 mM EGTA, and 10 mM {beta}-mercaptoethanol supplemented with PMSF and complete protease inhibitor mixture. Following lysis, NaCl was added to a final concentration of 0.5 M. The supernatant was incubated with amylose resin (New England Biolabs) overnight at 4 °C. After washing with 25 ml of column buffer (10 mM sodium phosphate, pH 7.2, 0.5 M NaCl, 10 mM {beta}-mercaptoethanol containing 0.25% Tween 20), the resin was packed in a column and washed with column buffer until the A280 of the flow-through was ~0. The bound protein was eluted with column buffer containing 10 mM maltose. MBP-Gle2 (kindly provided by L. Strawn) was purified as described previously (29).

Purified proteins were dialyzed into 20 mM Hepes, pH 6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, and 10% glycerol. Binding assays were conducted as described previously with 5 µg of proteins in binding buffer (20 mM Hepes, pH 6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, 10% glycerol, and 0.1% casamino acids). Bound and unbound fractions were separated on SDS polyacrylamide gels and detected by Coomassie staining.

Fluorescence Microscopy—Plasmids expressing Nab2-GFP or Nab2{Delta}RGG-GFP were transformed into wild type (SWY518), gle1-4 (SWY1191) or gfd1{Delta} cells by standard techniques. Stationary cultures grown in SC media lacking uracil (–ura) were diluted and grown overnight at 23 °C to early log phase. Half the culture was maintained at 23 °C and the other half shifted to 37 °C for 1 h. Cells were then labeled with Hoechst 33258 at a final concentration of 10 µg/ml, washed once in SC–ura, and viewed by direct fluorescence microscopy. Images were collected with a 100x objective on an Olympus BX50 microscope using a Photometric CoolSNAP HQ camera (Roper Scientific) and MetaVue software.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nab2 Interacts with Gfd1 in Two-hybrid and Biochemical Affinity Assays—In a recent report (54) of a genome-wide two-hybrid interaction analysis, an interaction between Nab2 and Gfd1 was reported. To test whether this two-hybrid result was potentially physiologically significant, we further analyzed the specificity of the two-hybrid interaction. In-frame fusions were generated for Gfd1 to the transcriptional activation domain of Gal4 (Gal4AD) and for Nab2 to the DNA binding domain of Gal4 (Gal4BD). These plasmids were cotransformed into reporter strains, and the presence of an interaction was assayed by growth on media lacking histidine and adenine. As controls for nonspecific interactions, we used fusions of the transcription factors Snf1 to Gal4BD and Snf4 to Gal4AD. As shown in Fig. 1A, a two-hybrid interaction was observed specifically between Nab2 and Gfd1 and not between Nab2 and Snf4 or Gfd1 and Snf1.



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 1.
Nab2 and Gfd1 form a complex. A, two-hybrid interaction between Nab2 and Gfd1. The indicated proteins were fused to Gal4BD or Gal4AD and expressed in the strain PJ69-4A. Positive interactions are indicated by growth on synthetic complete media lacking leucine, tryptophan, histidine, and adenine after 4 days at 30 °C. B, GST-Gfd1 or GST immobilized on glutathione-Sepharose beads was incubated with wild type yeast extract or buffer alone. Bound proteins were first eluted with high salt (1 M NaCl) and then with SDS sample buffer, followed by SDS-PAGE analysis, and immunoblotting with anti-Nab2 antibodies. Proteins were detected using anti-mouse IgG coupled to horseradish peroxidase. Samples loaded represent 1/20th of the total input compared with the total eluted fraction.

 
Next, we used an affinity chromatography assay to determine whether a physical interaction between Nab2 and Gfd1 could be detected in vitro. Gfd1 was expressed in bacteria as a fusion to glutathione S-transferase (GST) and bound to glutathione-Sepharose beads. The immobilized GST-Gfd1 was then incubated with buffer alone or total yeast lysate prepared under nondenaturing conditions. Bound proteins were sequentially eluted, first with high salt (1 M NaCl) followed by boiling in SDS buffer. Eluted fractions were separated by SDS-PAGE and analyzed by immunoblotting with monoclonal anti-Nab2 antibodies. Nab2 in the yeast lysate specifically bound to GST-Gfd1 and not GST alone (Fig. 1B, lanes 1 and 3). Additionally, the majority of Nab2 that was bound to GST-Gfd1 was eluted with high salt (Fig. 1B, lanes 1 and 5). The anti-Nab2 antibody did not recognize any proteins in the E. coli extract (Fig. 1B, lanes 2, 4, 6, and 8). These results are consistent with Nab2 forming a complex with Gfd1.

Nab2 Exists in a Complex with Gfd1 in Vivo—The identification of a physical in vitro interaction between recombinant GST-Gfd1 and endogenous Nab2 led us to ask whether a complex between the two endogenous factors could be isolated from yeast cell lysates. To approach this question, we generated a yeast strain with the sequence encoding GFP chromosomally integrated in-frame before the stop codon for GFD1. The lysates from Gfd1-GFP-expressing cells showed that a polypeptide of ~50 kDa was recognized by immunoblotting with polyclonal anti-GFP antibodies (data not shown). Next, we conducted coimmunoprecipitation studies with yeast lysates from wild type cells and Gfd1-GFP-expressing cells. After incubation of lysates with anti-GFP antibodies and protein A-Sepharose beads, the input and bound proteins were analyzed by SDS-PAGE and immunoblotting with anti-Nab2 antibodies. The blots revealed the presence of a single ~70-kDa protein only in the bound fraction from Gfd1-GFP lysates and not from wild type lysates (Fig. 2, lane 3). Our previous studies have shown that the anti-GFP antibodies are specific only for the GFP-tagged proteins (29). Taken together, these results strongly suggest that Gfd1 and Nab2 associate in a complex in vivo.



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 2.
Nab2 coimmunoprecipitates with Gfd1-GFP from yeast lysates. Extracts from wild type or Gfd1-GFP cells were immunoprecipitated (IP) with anti-GFP antibodies. Bound proteins were separated by SDS-PAGE and immunoblotted with anti-Nab2 antibodies. Proteins were detected using anti-mouse IgG coupled to horseradish peroxidase. Samples loaded represent 1/10th of the total input compared with the total bound fraction.

 
Recombinant Nab2 and Gfd1 Interact Directly—The interactions observed thus far did not indicate whether the binding between Gfd1 and Nab2 was direct or required the presence of other adaptor proteins. To analyze whether there was a direct and stable in vitro interaction, we performed soluble binding assays with purified recombinant proteins. Gfd1 was purified from bacteria as a fusion to GST and Nab2 as a fusion to maltose-binding protein (MBP). GST or GST-Gfd1 immobilized on glutathione-Sepharose beads was incubated with MBP-Nab2. Unbound and bound fractions were separated by SDS-PAGE and detected by Coomassie staining. As seen in Fig. 3A (lane 2) the ~50-kDa polypeptide corresponded to full-length GST-Gfd1, whereas purified MBP-Nab2 migrated as a major ~120-kDa protein (Fig. 3A, lane 3). Analysis of the unbound and bound fractions showed that MBP-Nab2 was found in the bound fraction together with GST-Gfd1 (Fig. 3B, lane 4). In contrast, MBP-Nab2 remained in the unbound fraction with immobilized GST alone (Fig. 3B, lane 1). To determine whether GST-Gfd1 bound MBP-Nab2 specifically, we tested the binding of MBP-Gle2. As shown in Fig. 3B (lanes 5 and 6), GST-Gfd1 did not bind MBP-Gle2. Therefore, the interaction between Gfd1 and Nab2 is direct and specific.



View larger version (37K):
[in this window]
[in a new window]
 
FIG. 3.
Nab2 and Gfd1 interact directly in vitro. Purified GST or GST-Gfd1 immobilized on glutathione-Sepharose beads was incubated with purified MBP-Nab2 (*) or MBP-Gle2 (**). Input proteins (A) and the unbound (U) and bound fractions (B) were resolved by SDS-PAGE and detected by Coomassie staining. The purified GST-Gfd1 contained full-length GST-Gfd1(<-) and two additional proteolytic bands.

 
The N-terminal Domain of Nab2 Binds Gfd1—Earlier studies have suggested four potential functional domains in Nab2. The N-terminal domain is required for export of both Nab2 and poly(A)+ RNA; the glutamine-rich domain is of unknown function, and the RGG and zinc finger regions are the RNA binding domains (15, 23). The RGG domain is also required for binding to the nuclear import factor, Kap104 (18). To identify the domain in Nab2 required for an interaction with Gfd1, the two-hybrid assay was used. A series of GBD-Nab2 deletion constructs were tested for a positive interaction with GAD-Gfd1. As summarized in Fig. 4, deletion of the RGG domain had no effect on the interaction with Gfd1. In contrast, deletion of the N-terminal and glutamine-rich regions abolished the interaction. Consistent with this result, a construct expressing the N-terminal and glutamine-rich domains was sufficient to observe a positive two-hybrid interaction. Additional two-hybrid analyses revealed that the N-terminal domain of Nab2 was sufficient for Gfd1 binding. Most interestingly, this indicated a role for a domain distinct from the RNA binding domains in Nab2, and we concluded that the N-terminal domain is necessary and sufficient for Gfd1 binding.



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 4.
The N-terminal domain of Nab2 interacts with Gfd1. A, domain structure of Nab2. Q-rich, glutamine; RGG, arginine, glycine; CCCH motif, cysteine, histidine (15, 23). B, a plasmid expressing Gal4AD-Gfd1was cotransformed with the indicated Gal4BD-Nab2 deletion plasmids into the PJ69-4A two-hybrid reporter strain. Positive interactions (+) are indicated by growth at 30 °C on synthetic complete media lacking leucine, tryptophan, histidine, and adenine.

 
Gle1 Is Required for Nab2 Export and Associates with Nab2-Gfd1 Complexes—Given that overexpression of GFD1 rescues the growth of gle1 and dbp5 mutants (40, 48), and Gfd1 interacted with the N-terminal domain of Nab2 (Fig. 4), we speculated that Gfd1 was a good candidate for facilitating Nab2 export. To test this possibility directly, we used an assay developed by Corbett and co-workers (23) to study Nab2 import and export. Plasmids expressing Nab2-GFP and Nab2{Delta}RGG-GFP were transformed into wild type and gfd1{Delta} mutant strains. At steady state in wild type cells, Nab2-GFP localizes to the nucleus, whereas Nab2{Delta}RGG-GFP localizes throughout the cell (Fig. 5A and Fig. 6A). Therefore, the localization of Nab2{Delta}RGG-GFP is a useful tool to study Nab2 export. Wild type and gfd1{Delta} cells were grown at 23 °C and shifted to 37 °C for 1 or 3 h (data not shown). To visualize the nuclei, cells were labeled with Hoechst dye after the temperature shift. In gfd1{Delta} cells, the localization of Nab2-GFP and Nab2{Delta}RGG-GFP was not perturbed at 23 °C or after incubation at 37 °C. Thus, Gfd1 was not required for efficient Nab2 export correlating with the finding that gfd1{Delta} cells do not demonstrate a detectable defect in viability or poly(A)+ RNA export (40, 48).



View larger version (78K):
[in this window]
[in a new window]
 
FIG. 5.
Nab2 import is not affected in gfd1{Delta} or gle1 mutants at 37 °C. Wild type (A–C), gfd1{Delta} (D–F), and gle1-4 (G–I) mutant cells harboring a Nab2-GFP plasmid were grown at 23 °C in synthetic media lacking uracil to log phase. Cells were maintained at 23 °C (data not shown) or shifted to 37 °C for 1 h before visualization by direct fluorescence microscopy (A, D, G). Corresponding Hoechst staining (middle; B, E, H) and Nomarski (right; C, F, I) are shown.

 



View larger version (62K):
[in this window]
[in a new window]
 
FIG. 6.
Nab2 export is blocked in a gle1 mutant at 37 °C. Wild type (A–C, J–L), gfd1{Delta}, (D–F, M–O), and gle1-4 (G–I, P–R) mutant cells harboring a Nab2{Delta}RGG-GFP plasmid were grown at 23 °C in synthetic media lacking uracil to early log phase. Cells were maintained at 23 °Cor shifted to 37 °C for 1 h before visualization by direct fluorescence microscopy (A, D, G, J, M, P). Corresponding Hoechst staining (middle; B, E, H, K, N, Q) and Nomarski (right; C, F, I, L, O, R) are shown.

 
Because Gfd1 physically associates with Gle1 (48), we speculated that Gfd1 could facilitate an interaction between Nab2 and Gle1. To determine whether Gle1 was also present in the Nab2-Gfd1 complex, we performed an affinity chromatography assay. Immobilized recombinant Nab2-GST or GST alone was incubated with yeast lysate from cells expressing Gle1-TAP-tagged. As shown in Fig. 7, Gle1-TAP-tagged and Gfd1 were coisolated in the bound fraction with Nab2-GST (lane 2) but not with GST alone (lane 3). Most interestingly, a greater proportion of the total Gfd1 was isolated compared with the relative fraction of bound Gle1-TAP-tagged. To test for a functional connection between Nab2 and Gle1, we used the Nab2 localization assay described above (Figs. 5 and 6). In a gle1-4 mutant, Nab2-GFP localized to the nucleus at both 23 °C and after a shift to the nonpermissive temperature, 37 °C, indicating that import was not affected (Fig. 5G). Strikingly, Nab2{Delta}RGG-GFP, which was localized throughout gle1-4 mutant cells at 23 °C, showed a marked nuclear accumulation at 37 °C (Fig. 6, G and P). These results suggested that Gle1 was physically connected to Nab2 complexes and was required specifically for Nab2 export but not Nab2 import.



View larger version (64K):
[in this window]
[in a new window]
 
FIG. 7.
Coisolation of endogenous Gfd1 and Gle1-TAP-tagged with Nab2-GST. Nab2-GST or GST immobilized on glutathione-Sepharose beads was incubated with Gle1-TAP-tagged yeast cell extract. Bound proteins were eluted with SDS sample buffer and analyzed by SDS-PAGE and immunoblotting with anti-Gle1 or anti-Gfd1 antibodies. Proteins were detected using anti-rabbit IgG coupled to horseradish peroxidase. Samples loaded represent 1/25th of the total input compared with the total bound fraction.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
To delineate the mechanism underlying mRNA transport through the NPC, it is essential to understand the interactions between shuttling hnRNPs and mRNA export factors. In this study, we report that the shuttling hnRNP Nab2 forms a complex with Gfd1. A role for Gfd1 in mRNA export has been implicated previously because of its interactions with Nup42 and the mRNA export factors Gle1 and Dbp5 (40, 48). We have assembled a series of biochemical data documenting direct Nab2-Gfd1 binding. This includes yeast two-hybrid assays, isolation of endogenous Nab2 using recombinant GST-Gfd1, Nab2 isolation by coimmunoprecipitation with Gfd1-GFP from yeast cell lysates, and soluble binding assays using purified recombinant Nab2 and Gfd1. Because previous in vivo and in vitro evidence has documented an interaction between Gfd1 and Gle1 (40, 48), Gfd1 could link Nab2 export to Gle1 function. Consistent with this conclusion, Nab2{Delta}RGG export is blocked at the restrictive temperature in a gle1-4 mutant. Moreover, endogenous Gfd1 and Gle1-TAP-tagged are coisolated using recombinant Nab2-GST. These results highlight a connection between Nab2- and Gle1-mediated mRNA export.

To date, Kap104 and Mlp1 are the only reported protein binding partners for Nab2 (18, 26). Incorporating our findings with this work, a model for Nab2 shuttling is presented in Fig. 8. Import is mediated by direct binding of Kap104 to the RGG domain of Nab2, and Nab2 accumulates in the cytoplasm of kap104-16 mutant cells (18, 19). Because Nab2{Delta}RGG enters the nucleus, it is possible that other factors may also mediate efficient import (23). However, a role for Kap104 in Nab2{Delta}RGG import has not been formally excluded. The FG Nups on both faces of the NPC likely represent the main docking sites for Kap104-mediated import. Nab2 import is perturbed when FG domains in specific Nups on both NPC faces are deleted (55). In the nucleus, the dissociation of Nab2 from Kap104 requires the dual interaction of Kap104 with RanGTP and Nab2 with RNA (18).



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 8.
Model for export of Nab2-bound mRNA. Nab2 import is mediated by Kap104 binding to the RGG domain and is also dependent on FG containing Nups (18, 19, 55). These FG Nups are localized on both faces of the NPC and could represent docking sites for Kap104. In the nucleus, Nab2 binds RNA during transcription and then shuttles to the cytoplasm transporting its cargo mRNA (20, 21). One of the first steps in its exit path is predicted to be binding with Mlp1 that localizes to the nuclear face of the NPC (26). The N-terminal domain of Nab2 is required for its export (23), and we report Gfd1 as a binding partner to this domain. Because Gfd1 and Gle1 interact (48) and Gle1 is present in Nab2-Gfd1 complexes, we propose that Nab2 could interact with Gle1 through Gfd1 to facilitate a terminal step in export.

 
For the export of Nab2, one of the first steps at the nuclear NPC face is predicted to be an interaction with Mlp1 (26). However, the Nab2 domain required for Mpl1 interaction has not yet been defined. Our results indicate that a step in the Nab2 export pathway also requires Gle1 function. Based on the lack of a two-hybrid interaction between Nab2 and Gle1 (data not shown), we propose that Gfd1 serves as a bridging factor between Nab2 and Gle1. We found that the Gfd1 binding region in the N-terminal Nab2 domain is distinct from the Nab2 RNA binding domains. Thus, Nab2 may bind mRNA and Gfd1 simultaneously at some point during the export pathway. As shown in Fig. 8, reported binding partners to Gle1 are Nup42, Nup159, Dbp5, and Gfd1 (40, 48). The DEAD box RNA helicase Dbp5 also interacts with Nup159 and Gfd1, and Nup42 interacts with Gfd1 (40). Because Nup42 and Nup159 localize to the cytoplasmic NPC face (2), the Gle1-Gfd1-Nab2 complex may form at a terminal step in export. However, a Gle1-ProtA fusion protein has been localized to both faces of the NPC (2), and hGle1 is known to shuttle between the nucleus and cytoplasm (49). Therefore, the Nab2-Gfd1 complex could interact with Gle1 at both NPC faces. Once in the cytoplasm, Nab2 will be released from the mRNA upon binding to Kap104 and then imported into the nucleus for further rounds of transport.

Throughout the mRNA export pathway and as shown in part for Nab2 shuttling in Fig. 8, a number of individual protein-protein interactions have been documented (reviewed in Refs. 4 and 13). However, both the formation of an export-competent hnRNP and the NPC translocation mechanism are likely based on combinatorial and/or overlapping protein-protein interaction networks. For example, we predict additional factors may bind to the N-terminal domain of Nab2 and compensate for the absence of Gfd1. The growth and mRNA export defects observed in nab2{Delta}N mutant cells are not present in gfd1{Delta} mutant cells (40, 48), and we found that Nab2 export is not impaired in gfd1{Delta} mutant cells. We speculate that Gfd1 and the other functionally redundant proteins serve as bridging factors between Nab2 and Gle1, other mRNA export factors, or Nups. We have also shown previously (56) that inositol hexakisphosphate production is required for efficient Gle1-mediated mRNA export. Any of these steps along the Gle1 pathway may be modulated by inositol hexakisphosphate.

It is uncertain whether yeast and human Gle1 utilize similar mechanistic pathways to mediate mRNA export. The ability of yeast-human Gle1 chimera proteins to complement gle1 mutant cells suggests that the pathways may be functionally conserved (56). Four putative functional domains have been identified in hGle1 (49, 57, 58). Both the N- and C-terminal domains are required for NPC localization (49, 58). In addition, there is a coiled-coil domain and a region required for nucleocytoplasmic shuttling (49). Thus far, the only binding partner identified for hGle1 is the NPC-localized hNup155 (58). If the yeast and human pathways are analogous, adaptor proteins similar to Gfd1 could facilitate interactions between hGle1 and shuttling hnRNPs in vertebrate cells.

It has been the long standing view in the field that Mex67/Tap/NXF1 serves as the transporter for exporting hnRNPs (13). This is based on Mex67/Tap/NXF1 nucleocytoplasmic shuttling and essential interactions with both the RNA-bound Yra1 and nucleoporins. The studies in this paper, combined with previous work, have now linked Gle1 both with an RNA-bound protein (Nab2) and nucleoporins (36, 40, 46, 47, 48, 58) and have shown Gle1 shuttling or having access to both NPC faces (2, 49). Thus, Gle1 is also positioned to play an active role in the translocation mechanism. However, Gle1 and Mex67 clearly function differently in the mRNA export pathway. In cells overexpressing the Nup116 GLFG region, Mex67-GFP accumulates in the nucleus whereas Gle1-GFP remains predominantly localized at NPCs (29). Moreover, they interact with distinct domains in Nup42; Mex67 binds the N-terminal FG repeat region of Nup42 and Gle1 binds exclusively the C-terminal Nup42 non-FG domain (28, 48). We have also not observed any synthetic lethal genetic interactions between gle1 and mex67 mutants.2 Moreover, in S. pombe MEX67 is not essential for viability as it is in S. cerevisiae (59). This could reflect nonoverlapping export pathways for distinct hnRNPs being either Gle1- or Mex67-mediated. Alternatively, we hypothesize that they act at distinct steps in a common pathway. Mex67 may load early onto the RNA during transcription and pre-mRNA processing (22), whereas Gle1 may intersect later at the stage of NPC translocation. To resolve such sequential steps, future studies will need to be aimed at pinpointing the spatial and temporal determinants of Gle1 and Mex67 interactions with shuttling hnRNP proteins and the NPC.


    FOOTNOTES
 
* This work was supported by National Institutes of Health Grant GM51219 (to S. R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} Present address: Medical Scientist Training Program, Washington University School of Medicine, St. Louis, MO 63110. Back

§ To whom correspondence should be addressed: Dept. of Cell and Developmental Biology, Vanderbilt University Medical Center, 3120 MRBIII, 465 21st Ave. South, Nashville, TN 37232. Tel.: 615-936-3443; Fax: 615-936-3439; E-mail: susan.wente{at}vanderbilt.edu.

1 The abbreviations used are: NPC, nuclear pore complex; DTT, dithiothreitol; Gal4AD, Gal4 transcriptional activation domain; Gal4BD, Gal4 transcriptional binding domain; GFP, green fluorescent protein; GST, glutathione S-transferase; hnRNP, heterogeneous nuclear ribonucleoprotein; Kap, karyopherin; MBP, maltose-binding protein; Nup, nucleoporin; PMSF, phenylmethylsulfonyl fluoride; SC, synthetic complete; TAP-tagged, tandem affinity purification tagged; h, human. Back

2 S. Johnson and S. R. Wente, personal communication. Back


    ACKNOWLEDGMENTS
 
We are grateful to John Aitchison, Anita Corbett, Philip James, Maurine Linder, Tianxiang Shen, and Lisa Strawn for generously sharing strains, plasmids, and reagents. We thank Charles Cole, Anita Corbett, and members of the Wente laboratory for valuable discussion and comments on the manuscript.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Fahrenkrog, B., and Aebi, U. (2003) Nat. Rev. Mol. Cell Biol. 4, 757–766[Medline] [Order article via Infotrieve]
  2. Rout, M. P., Aitchison, J. D., Suprapto, A., Hjertaas, K., Zhao, Y., and Chait, B. T. (2000) J. Cell Biol. 148, 635–651[Abstract/Free Full Text]
  3. Cronshaw, J. M., Krutchinsky, A. N., Zhang, W., Chait, B. T., and Matunis, M. J. (2002) J. Cell Biol. 158, 915–927[Abstract/Free Full Text]
  4. Lei, E. P., and Silver, P. A. (2002) Dev. Cell 2, 261–272[CrossRef][Medline] [Order article via Infotrieve]
  5. Ribbeck, K., and Gorlich, D. (2001) EMBO J. 20, 1320–1330[CrossRef][Medline] [Order article via Infotrieve]
  6. Smith, A. E., Slepchenko, B. M., Schaff, J. C., Loew, L. M., and Macara, I. G. (2002) Science 295, 488–491[Abstract/Free Full Text]
  7. Weis, K. (2003) Cell 112, 441–451[CrossRef][Medline] [Order article via Infotrieve]
  8. Mattaj, I. W., and Englmeier, L. (1998) Annu. Rev. Biochem. 67, 265–306[CrossRef][Medline] [Order article via Infotrieve]
  9. Suntharalingam, M., and Wente, S. R. (2003) Dev. Cell 4, 775–789[CrossRef][Medline] [Order article via Infotrieve]
  10. Gorlich, D., and Kutay, U. (1999) Annu. Rev. Cell Dev. Biol. 15, 607–660[CrossRef][Medline] [Order article via Infotrieve]
  11. Bednenko, J., Cingolani, G., and Gerace, L. (2003) Traffic 4, 127–135[Medline] [Order article via Infotrieve]
  12. Nakielny, S., and Dreyfuss, G. (1998) Curr. Biol. 8, 89–95[CrossRef][Medline] [Order article via Infotrieve]
  13. Reed, R., and Hurt, E. (2002) Cell 108, 523–531[CrossRef][Medline] [Order article via Infotrieve]
  14. Mili, S., Shu, H. J., Zhao, Y., and Pinol-Roma, S. (2001) Mol. Cell. Biol. 21, 7307–7319[Abstract/Free Full Text]
  15. Anderson, J. T., Wilson, S. M., Datar, K. V., and Swanson, M. S. (1993) Mol. Cell. Biol. 13, 2730–2741[Abstract/Free Full Text]
  16. Kessler, M. M., Henry, M. F., Shen, E., Zhao, J., Gross, S., Silver, P. A., and Moore, C. L. (1997) Genes Dev. 11, 2545–2556[Abstract/Free Full Text]
  17. Flach, J., Bossie, M., Vogel, J., Corbett, A., Jinks, T., Willins, D. A., and Silver, P. A. (1994) Mol. Cell. Biol. 14, 8399–8407[Abstract/Free Full Text]
  18. Lee, D. C., and Aitchison, J. D. (1999) J. Biol. Chem. 274, 29031–29037[Abstract/Free Full Text]
  19. Aitchison, J. D., Blobel, G., and Rout, M. P. (1996) Science 274, 624–627[Abstract/Free Full Text]
  20. Hector, R. E., Nykamp, K. R., Dheur, S., Anderson, J. T., Non, P. J., Urbinati, C. R., Wilson, S. M., Minvielle-Sebastia, L., and Swanson, M. S. (2002) EMBO J. 21, 1800–1810[CrossRef][Medline] [Order article via Infotrieve]
  21. Gallardo, M., Luna, R., Erdjument-Bromage, H., Tempst, P., and Aguilera, A. (2003) J. Biol. Chem. 278, 24225–24232[Abstract/Free Full Text]
  22. Rodriguez-Navarro, S., Fischer, T., Luo, M. J., Antunez, O., Brettschneider, S., Lechner, J., Perez-Ortin, J. E., Reed, R., and Hurt, E. (2004) Cell 116, 75–86[CrossRef][Medline] [Order article via Infotrieve]
  23. Marfatia, K. A., Crafton, E. B., Green, D. M., and Corbett, A. H. (2003) J. Biol. Chem. 278, 6731–6740[Abstract/Free Full Text]
  24. Duncan, K., Umen, J. G., and Guthrie, C. (2000) Curr. Biol. 10, 687–696[CrossRef][Medline] [Order article via Infotrieve]
  25. Green, D. M., Marfatia, K. A., Crafton, E. B., Zhang, X., Cheng, X., and Corbett, A. H. (2002) J. Biol. Chem. 277, 7752–7760[Abstract/Free Full Text]
  26. Green, D. M., Johnson, C. P., Hagan, H., and Corbett, A. H. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 1010–1015[Abstract/Free Full Text]
  27. Santos-Rosa, H., Moreno, H., Simos, G., Segref, A., Fahrenkrog, B., Pante, N., and Hurt, E. (1998) Mol. Cell. Biol. 18, 6826–6838[Abstract/Free Full Text]
  28. Strasser, K., Bassler, J., and Hurt, E. (2000) J. Cell Biol. 150, 695–706[Abstract/Free Full Text]
  29. Strawn, L. A., Shen, T., and Wente, S. R. (2001) J. Biol. Chem. 276, 6445–6452[Abstract/Free Full Text]
  30. Strasser, K., and Hurt, E. (2001) Nature 413, 648–652[CrossRef][Medline] [Order article via Infotrieve]
  31. Strasser, K., Masuda, S., Mason, P., Pfannstiel, J., Oppizzi, M., Rodriguez-Navarro, S., Rondon, A. G., Aguilera, A., Struhl, K., Reed, R., and Hurt, E. (2002) Nature 417, 304–308[CrossRef][Medline] [Order article via Infotrieve]
  32. Zenklusen, D., Vinciguerra, P., Wyss, J. C., and Stutz, F. (2002) Mol. Cell. Biol. 22, 8241–8253[Abstract/Free Full Text]
  33. Tseng, S. S., Weaver, P. L., Liu, Y., Hitomi, M., Tartakoff, A. M., and Chang, T. H. (1998) EMBO J. 17, 2651–2662[CrossRef][Medline] [Order article via Infotrieve]
  34. Zhao, J., Jin, S. B., Bjorkroth, B., Wieslander, L., and Daneholt, B. (2002) EMBO J. 21, 1177–1187[CrossRef][Medline] [Order article via Infotrieve]
  35. Snay-Hodge, C. A., Colot, H. V., Goldstein, A. L., and Cole, C. N. (1998) EMBO J. 17, 2663–2676[CrossRef][Medline] [Order article via Infotrieve]
  36. Murphy, R., and Wente, S. R. (1996) Nature 383, 357–360[CrossRef][Medline] [Order article via Infotrieve]
  37. Murphy, R., Watkins, J. L., and Wente, S. R. (1996) Mol. Biol. Cell 7, 1921–1937[Abstract]
  38. Brown, J. A., Bharathi, A., Ghosh, A., Whalen, W., Fitzgerald, E., and Dhar, R. (1995) J. Biol. Chem. 270, 7411–7419[Abstract/Free Full Text]
  39. Schmitt, C., von Kobbe, C., Bachi, A., Pante, N., Rodrigues, J. P., Boscheron, C., Rigaut, G., Wilm, M., Seraphin, B., Carmo-Fonseca, M., and Izaurralde, E. (1999) EMBO J. 18, 4332–4347[CrossRef][Medline] [Order article via Infotrieve]
  40. Hodge, C. A., Colot, H. V., Stafford, P., and Cole, C. N. (1999) EMBO J. 18, 5778–5788[CrossRef][Medline] [Order article via Infotrieve]
  41. Estruch, F., and Cole, C. N. (2003) Mol. Biol. Cell 14, 1664–1676[Abstract/Free Full Text]
  42. Ho, A. K., Raczniak, G. A., Ives, E. B., and Wente, S. R. (1998) Mol. Biol. Cell 9, 355–373[Abstract/Free Full Text]
  43. Bailer, S. M., Siniossoglou, S., Podtelejnikov, A., Hellwig, A., Mann, M., and Hurt, E. (1998) EMBO J. 17, 1107–1119[CrossRef][Medline] [Order article via Infotrieve]
  44. Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., and van Deursen, J. M. (2003) J. Cell Biol. 160, 341–353[Abstract/Free Full Text]
  45. Blevins, M. B., Smith, A. M., Phillips, E. M., and Powers, M. A. (2003) J. Biol. Chem. 278, 20979–20988[Abstract/Free Full Text]
  46. Del Priore, V., Snay, C. A., Bahr, A., and Cole, C. N. (1996) Mol. Biol. Cell 7, 1601–1621[Abstract]
  47. Stutz, F., Kantor, J., Zhang, D., McCarthy, T., Neville, M., and Rosbash, M. (1997) Genes Dev. 11, 2857–2868[Abstract/Free Full Text]
  48. Strahm, Y., Fahrenkrog, B., Zenklusen, D., Rychner, E., Kantor, J., Rosbach, M., and Stutz, F. (1999) EMBO J. 18, 5761–5777[CrossRef][Medline] [Order article via Infotrieve]
  49. Kendirgi, F., Barry, D. M., Griffis, E. R., Powers, M. A., and Wente, S. R. (2003) J. Cell Biol. 160, 1029–1040[Abstract/Free Full Text]
  50. Baudin, A., Ozier-Kalogeropoulos, O., Denouel, A., Lacroute, F., and Cullin, C. (1993) Nucleic Acids Res. 21, 3329–3330[Free Full Text]
  51. James, P., Halladay, J., and Craig, E. A. (1996) Genetics 144, 1425–1436[Abstract]
  52. Allen, N. P., Huang, L., Burlingame, A., and Rexach, M. (2001) J. Biol. Chem. 276, 29268–29274[Abstract/Free Full Text]
  53. Ho, A. K., Shen, T. X., Ryan, K. J., Kiseleva, E., Levy, M. A., Allen, T. D., and Wente, S. R. (2000) Mol. Cell. Biol. 20, 5736–5748[Abstract/Free Full Text]
  54. Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., Qureshi-Emili, A., Li, Y., Godwin, B., Conover, D., Kalbfleisch, T., Vijayadamodar, G., Yang, M., Johnston, M., Fields, S., and Rothberg, J. M. (2000) Nature 403, 623–627[CrossRef][Medline] [Order article via Infotrieve]
  55. Strawn, L. A., Shen, T., Shulga, N., Goldfarb, D., and Wente, S. R. (2004) Nat. Cell Biol. 6, 197–206[Medline] [Order article via Infotrieve]
  56. York, J. D., Odom, A. R., Murphy, R., Ives, E. B., and Wente, S. R. (1999) Science 285, 96–100[Abstract/Free Full Text]
  57. Watkins, J. L., Murphy, R., Emtage, J. L., and Wente, S. R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6779–6784[Abstract/Free Full Text]
  58. Rayala, H. J., Kendirgi, F., Barry, D. M., Majerus, P. A., and Wente, S. R. (2004) Mol. Cell. Proteomics 3, 145–155[Abstract/Free Full Text]
  59. Yoon, J. H., Love, D. C., Guhathakurta, A., Hanover, J. A., and Dhar, R. (2000) Mol. Cell. Biol. 20, 8767–8782[Abstract/Free Full Text]
  60. Bucci, M., and Wente, S. R. (1997) J. Cell Biol. 136, 1185–1199[Abstract/Free Full Text]
  61. Yang, X., Hubbard, E. J., and Carlson, M. (1992) Science 257, 680–682[Abstract/Free Full Text]
  62. Ghaemmaghami, S., Huh, W., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, E. K., and Weissman, J. S. (2003) Nature 425, 737–741[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. B. Fasken, M. Stewart, and A. H. Corbett
Functional Significance of the Interaction between the mRNA-binding Protein, Nab2, and the Nuclear Pore-associated Protein, Mlp1, in mRNA Export
J. Biol. Chem., October 3, 2008; 283(40): 27130 - 27143.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Fuke and M. Ohno
Role of poly (A) tail as an identity element for mRNA nuclear export
Nucleic Acids Res., February 11, 2008; 36(3): 1037 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Kelly, S. A. Pabit, C. M. Kitchen, P. Guo, K. A. Marfatia, T. J. Murphy, A. H. Corbett, and K. M. Berland
Recognition of polyadenosine RNA by zinc finger proteins
PNAS, July 24, 2007; 104(30): 12306 - 12311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sheng, C.-H. Tsai-Morris, R. Gutti, Y. Maeda, and M. L. Dufau
Gonadotropin-regulated Testicular RNA Helicase (GRTH/Ddx25) Is a Transport Protein Involved in Gene-specific mRNA Export and Protein Translation during Spermatogenesis
J. Biol. Chem., November 17, 2006; 281(46): 35048 - 35056.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Kendirgi, D. J. Rexer, A. R. Alcazar-Roman, H. M. Onishko, and S. R. Wente
Interaction between the Shuttling mRNA Export Factor Gle1 and the Nucleoporin hCG1: A Conserved Mechanism in the Export of Hsp70 mRNA
Mol. Biol. Cell, September 1, 2005; 16(9): 4304 - 4315.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Estruch, C. A. Hodge, S. Rodriguez-Navarro, and C. N. Cole
Physical and Genetic Interactions Link the Yeast Protein Zds1p with mRNA Nuclear Export
J. Biol. Chem., March 11, 2005; 280(10): 9691 - 9697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Miller, M. Suntharalingam, S. L. Johnson, A. Audhya, S. D. Emr, and S. R. Wente
Cytoplasmic Inositol Hexakisphosphate Production Is Sufficient for Mediating the Gle1-mRNA Export Pathway
J. Biol. Chem., December 3, 2004; 279(49): 51022 - 51032.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/34/35384    most recent
M402044200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suntharalingam, M.
Right arrow Articles by Wente, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suntharalingam, M.
Right arrow Articles by Wente, S. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement